-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The clinical trial of pruceline for the treatment of severe neo-crown patients is a multi-center, randomized, double-blind, placebo parallel-controlled study initiated by researchers to explore the effectiveness of psylone in patients with severe neo-coronary disease.
The clinical trial program recruited 294 male and 294 female patients and included them in the "pruamine plus standard treatment" trial group and the "placebo plus standard treatment" control group, all of whom were hospitalized with new crown patients 18 years of age and older, respectively.
group, patients were orally taking 300 mg of psyruamine once a day for 14 days.
control group, patients were given a 300 mg placebo once a day for 14 days.
end of clinical trials was the effectiveness of the 14-day proclosamine treatment group relative to the control group (assessed by the WHO 8 scale).
note: There are deletions in the original text